Swiss generic drug manufacturer Sandoz has agreed to pay $275 million to resolve claims by U.S. consumers and others who ...
Expected out-of-pocket costs for commonly prescribed brand name medications have grown substantially for Medicare Part D ...
A new study from the USC Schaeffer Center shows that out-of-pocket costs for brand-name medications have increased sharply ...
The DOJ backs Medicare price negotiations amidst a Novartis lawsuit, while President Trump vows to lower U.S. drug costs.
Providers are sympathetic to Medicare enrollees’ concerns but don’t agree on their role in helping patients find less costly ...
While Trump's tariffs could have a broad impact on healthcare prices, it is likely they will not have the devastating result ...
The FDA has announced that the shortage of Wegovy and Ozempic, medications used for weight loss and diabetes management, is ...
The U.S. Department of Justice has filed an appeals court brief supporting the right of Medicare officials to negotiate ...
13don MSN
Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper savings to outdo his predecessor.
Medicare recipients are facing unprecedented increases in their prescription drug costs, with some medications nearly tripling in price.
Debate over whether or not the Affordable Care Act, commonly known as Obamacare, worked and how President Trump's executive ...
“Governor Maura Healey’s proposal, to increase costs for prescription drugs, is absolutely ‘ill’ advised. Healthcare costs in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results